News
A group of researchers in the lab of Prof. Lucía Chávez Gutiérrez (VIB-KU Leuven) has unraveled the genetic contributions to ...
FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...
This lack of lung movement, Di Bon explained, makes EDS patients more vulnerable to complications from respiratory diseases such as COVID-19 and pneumonia. To make matters worse, Taylor Goldberg ...
on December 10, 2024. US Coast Guard Photo Two Louisiana-based shipbuilders are teaming up to pitch the Coast Guard on designs for the Arctic Security Cutter, according to a statement from the ...
May 5, 2025 — People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a recent study ...
Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent Post-TB Lung Disease, Study Suggests Apr. 21, 2025 — An experimental drug now in clinical trials as a cancer ...
There were other adversities. Hoke had to learn to perform dialysis when her husband was diagnosed with kidney disease. He died in 1981. She lived through the loss of five of her six children. Don't ...
Data was also presented of the long term follow-up Phase 1 results which demonstrated Complete Response and Disease Free Survival in both CIS and Papillary disease, with patients in on-going ...
Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...
France’s Sanofi – a major player in the rare disease category – is offering $30 per share for La Jolla, California-based Inhibrx, which had a closing price of just over $33 yesterday.
The medical research on human subjects has to respect the ethical principles included in the Declaration of Helsinki and the additional constraints imposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results